Patterns of response/progression and management following progressive disease (PD) with anti-PD-(L)1 (PD(L)1) in patients (pts) with advanced Merkel cell carcinoma (MCC)

Mo, J; Zaremba, A; Inderjeeth, AJ; El Zenaity, P; Li, A; Wicky, A; Della Marta, N; Marqueste, CG; Bohne, AS; Festino, L; Chen, C; Lo, SN; Guminski, A; Michielin, OA; Xu, W; Lebbe, C; Sandhu, SK; Zimmer, L; Carlino, MS; Da Silva, IP

ANNALS OF ONCOLOGY, 2022; 33 (7): S924